2seventy bio, Inc.
TSVT
$3.92
$0.143.70%
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 36.05M | 41.62M | 56.18M | 13.41M | 13.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.05M | 41.62M | 56.18M | 13.41M | 13.48M |
| Cost of Revenue | 64.50M | 72.54M | 64.64M | 62.12M | 73.09M |
| Gross Profit | -28.45M | -30.92M | -8.46M | -48.71M | -59.61M |
| SG&A Expenses | 19.49M | 20.72M | 18.70M | 19.61M | 17.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.99M | 93.26M | 83.34M | 81.73M | 90.37M |
| Operating Income | -47.94M | -51.64M | -27.16M | -68.32M | -76.89M |
| Income Before Tax | -42.09M | -47.02M | -23.16M | -67.88M | -77.42M |
| Income Tax Expenses | -- | -- | -17.00K | -- | -- |
| Earnings from Continuing Operations | -42.09M | -47.02M | -23.14M | -67.88M | -77.42M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.09M | -47.02M | -23.14M | -67.88M | -77.42M |
| EBIT | -47.94M | -51.64M | -27.16M | -68.32M | -76.89M |
| EBITDA | -45.70M | -49.39M | -24.84M | -65.94M | -73.59M |
| EPS Basic | -0.83 | -1.08 | -0.60 | -1.76 | -2.02 |
| Normalized Basic EPS | -0.52 | -0.68 | -0.37 | -1.10 | -1.26 |
| EPS Diluted | -0.83 | -1.08 | -0.60 | -1.76 | -2.02 |
| Normalized Diluted EPS | -0.52 | -0.68 | -0.37 | -1.10 | -1.26 |
| Average Basic Shares Outstanding | 50.97M | 43.47M | 38.68M | 38.57M | 38.38M |
| Average Diluted Shares Outstanding | 50.97M | 43.47M | 38.68M | 38.57M | 38.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
